Evidence map›Paper›PMID 30736353›Full record

ArticleNutrients2019

Tryptophan-Tyrosine Dipeptide, the Core Sequence of β-Lactolin, Improves Memory by Modulating the Dopamine System.

Yasuhisa Ano, Tatsuhiro Ayabe, Rena Ohya, Keiji Kondo, Shiho Kitaoka, Tomoyuki Furuyashiki

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. The effects ofFrontiers in nutrition · 2025
    Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yasuhisa AnoResearch Laboratories for Health Science & Food Technologies, Kirin Company Ltd, Kanazawa-ku, Yokohama-shi, Kanagawa 236-0004, Japan. Yasuhisa_Ano@kirin.co.jp.ORCID 0000-0001-5957-8710
Tatsuhiro AyabeResearch Laboratories for Health Science & Food Technologies, Kirin Company Ltd, Kanazawa-ku, Yokohama-shi, Kanagawa 236-0004, Japan. Tatsuhiro_Ayabe@kirin.co.jp.
Rena OhyaResearch Laboratories for Health Science & Food Technologies, Kirin Company Ltd, Kanazawa-ku, Yokohama-shi, Kanagawa 236-0004, Japan. Rena_Ohya@kirin.co.jp.
Keiji KondoResearch Laboratories for Health Science & Food Technologies, Kirin Company Ltd, Kanazawa-ku, Yokohama-shi, Kanagawa 236-0004, Japan. kondok@kirin.co.jp.
Shiho KitaokaDivision of Pharmacology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan. skitaoka@med.kobe-u.ac.jp.
Tomoyuki FuruyashikiDivision of Pharmacology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan. tfuruya@med.kobe-u.ac.jp.
Kyowa Kirin (Japan) · JPJapan Agency for Medical Research and Development · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tryptophan-tyrosine (WY)-related peptides including the β-lactopeptide of the glycine-threonine-tryptophan-tyrosine peptide, β-lactolin, improve spatial memory. However, whether and how the WY dipeptide as the core sequence in WY-related peptides improves memory functions has not been investigated. This study assessed the pharmacological effects of the WY dipeptide on memory impairment to elucidate the mechanisms. Here, we showed that oral administration of dipeptides of WY, tryptophan-methionine (WM), tryptophan-valine, tryptophan-leucine, and tryptophan-phenylalanine improved spontaneous alternation of the Y-maze test in scopolamine-induced amnesic mice. In contrast, tyrosine-tryptophan, methionine-tryptophan, tryptophan, tyrosine, and methionine had no effect. These results indicated that the conformation of dipeptides with N-terminal tryptophan is required for their memory improving effects. WY dipeptide inhibited the monoamine oxidase B activity in vitro and increased dopamine levels in the hippocampus and frontal cortex, whereas tryptophan did not cause these effects. In addition, the treatment with SCH-23390, a dopamine D1-like receptor antagonist, and the knockdown of the hippocampal dopamine D1 receptor partially attenuated the memory improvement induced by the WY dipeptide. Importantly, WY dipeptide improved the spontaneous alternations of the Y-maze test in aged mice. These results suggest that the WY dipeptide restores memory impairments by augmenting dopaminergic activity. The development of supplements rich in these peptides might help to prevent age-related cognitive decline.

Indexed as

AmnesiaAnimalsDipeptidesDisease Models, AnimalDopamineFrontal LobeHippocampusMaleMaze LearningMemoryMiceMice, Inbred C57BLScopolamineTryptophanTyrosineDipeptidesDopamineScopolamineTryptophanTyrosinedipeptidedopaminehippocampusmemorymonoamine oxidase B

Identifiers

PMID30736353
PMCPMC6412195
OpenAlexW2911833800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.